TABLE 1.
Study group characteristicsa
Study group | Patient ID | Age (yr) | CDC classification | Duration of infection (wk) | Peripheral CD4+ T-cell count |
---|---|---|---|---|---|
Primary HIV infection | E116 | 34 | A1 | 6 | 1,000 |
E134 | 35 | A1 | 4 | 694 | |
E56 | 33 | A1 | 4 | 696 | |
E154 | 32 | A1 | 8 | 915 | |
Uninfected controls | N8 | 22 | NA | NA | 1,046 |
N12 | 22 | NA | NA | 1,236 | |
N15 | 52 | NA | NA | ND | |
N34 | 35 | NA | NA | 1,046 | |
N38 | 48 | NA | NA | 632 | |
N41 | 43 | NA | NA | 1,203 | |
N65 | 37 | NA | NA | 634 | |
N151 | 44 | NA | NA | 899 | |
N153 | 50 | NA | NA | 406 | |
N188 | 28 | NA | NA | 620 |
ID, patient identification number; NA, not applicable.